ESKAPE and MDRO Pathogens: Infections and Antimicrobial Treatment
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 463
Special Issue Editor
Interests: antimicrobial resistance; difficult-to-treat infections; endocarditis; antimicrobial stewardship; infection of the central nervous system
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
ESKAPE and MDRO pathogens are still a growing concern, with an estimated enormous mortality in next decades. New antibiotics are going to be available and others are progressing in the pipeline. The appropriate use of these antibiotics should be a cornerstone of our daily activities in order to preserve them and to reduce the clinical and economical impact of antibiotic resistance.
Several questions are still open in the field of antibiotic treatment: role of combination therapy, treatment duration, antibiotics administration, and place in therapy of BLIC and new antibiotics, among many others.
This Special Issue will contribute to answering these and other arising questions about the treatment of ESKAPE and other MDRO infections.
Dr. Carlo Pallotto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ESKAPE
- MDRO
- Escherichia coli
- Staphylococcus aureus
- Klebsiella pneumoniae
- Acinetobacter baumannii
- Pseudomonas aeruginosa
- Enterococcus faecalis
- Enterococcus faecium
- Stenotrophomonas maltophilia
- Enterobacter cloacae
- antimicrobial stewardship
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
